LifeMine
is a Massachusetts-based clinical-stage biopharmaceutical company that develops genomically-enabled small molecule drugs for the treatment of chronic diseases... Read moreLifeMine
is a Massachusetts-based clinical-stage biopharmaceutical company that develops genomically-enabled small molecule drugs for the treatment of chronic diseases... Read more
News
Apr 09, 2025
Clinical Trials Arena
LifeMine: LifeMine Therapeutics doses first subject in Phase I trial of LIFE-001
Oct 16, 2024
REBusinessOnline
LifeMine: LifeMine Signs 56,456 SF Life Sciences Lease in Watertown, Massachusetts
Jan 11, 2024
Endpoints News
LifeMine: #JPM24: Greg Verdine's LifeMine eyes the clinic next year with T-cell immunosuppressive and antifungal
Mar 25, 2022
Global Legal Chronicle
LifeMine: LifeMine Therapeutics' $175 Million Series C Financing
Mar 24, 2022
Pharamceutical Technology
LifeMine: LifeMine and GSK sign partnership for small molecule leads
Mar 24, 2022
Pharmaphorum
LifeMine: GSK partners LifeMine on fungi-derived medicines
Mar 23, 2022
Benzinga
LifeMine: LifeMine Therapeutics, GSK Ink $70M Drug Discovery, Development Pact
Mar 23, 2022
MedCity News
LifeMine: GSK joins LifeMine's $175M funding as partners revive fungi as a drug discovery frontier
Mar 22, 2022
FierceBiotechIT
LifeMine: LifeMine locks down $70M 'dream scenario' fungi partnership with GSK-and a fundraising, too
Jan 13, 2021
Global University Venturing
LifeMine Therapeutics: LifeMine Therapeutics lands $50m - Global University Venturing
LifeMine Competitors
1
2
3
4
5
6
7
8
9
10